Significant Impact of Coronavirus Disease 2019 (COVID-19) on Human Immunodeficiency Virus (HIV) Care in Hospitals Affecting the First Pillar of the HIV Care Continuum
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissionsoup.com..
During COVID-19 lockdown, the in-hospital number of HIV indicator conditions decreased disproportionally compared with other non-COVID-19 diseases, which was accompanied by reduced HIV testing rates, number and proportion of positive HIV tests, and new HIV referrals, with more late presentation after lockdown cessation, indicating a significantly impacted HIV care continuum.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:74 |
---|---|
Enthalten in: |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 74(2022), 3 vom: 11. Feb., Seite 521-524 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Hensley, Kathryn S [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 impact |
---|
Anmerkungen: |
Date Completed 16.02.2022 Date Revised 16.02.2022 published: Print Citation Status MEDLINE |
---|
doi: |
10.1093/cid/ciab445 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM32544577X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM32544577X | ||
003 | DE-627 | ||
005 | 20231225192444.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1093/cid/ciab445 |2 doi | |
028 | 5 | 2 | |a pubmed24n1084.xml |
035 | |a (DE-627)NLM32544577X | ||
035 | |a (NLM)33993276 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Hensley, Kathryn S |e verfasserin |4 aut | |
245 | 1 | 0 | |a Significant Impact of Coronavirus Disease 2019 (COVID-19) on Human Immunodeficiency Virus (HIV) Care in Hospitals Affecting the First Pillar of the HIV Care Continuum |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 16.02.2022 | ||
500 | |a Date Revised 16.02.2022 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissionsoup.com. | ||
520 | |a During COVID-19 lockdown, the in-hospital number of HIV indicator conditions decreased disproportionally compared with other non-COVID-19 diseases, which was accompanied by reduced HIV testing rates, number and proportion of positive HIV tests, and new HIV referrals, with more late presentation after lockdown cessation, indicating a significantly impacted HIV care continuum | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a COVID-19 impact | |
650 | 4 | |a HIV | |
650 | 4 | |a HIV testing | |
650 | 4 | |a care continuum | |
650 | 4 | |a indicator conditions | |
700 | 1 | |a Jordans, Carlijn C E |e verfasserin |4 aut | |
700 | 1 | |a van Kampen, Jeroen J A |e verfasserin |4 aut | |
700 | 1 | |a Mollema, Femke P N |e verfasserin |4 aut | |
700 | 1 | |a Gisolf, Elisabeth H |e verfasserin |4 aut | |
700 | 1 | |a El Moussaoui, Rachida |e verfasserin |4 aut | |
700 | 1 | |a Hermanides, Gonneke |e verfasserin |4 aut | |
700 | 1 | |a van Beek, Jan E A |e verfasserin |4 aut | |
700 | 1 | |a Vriesde, Marion E |e verfasserin |4 aut | |
700 | 1 | |a Finkenflügel, Renée N N |e verfasserin |4 aut | |
700 | 1 | |a Rijnders, Bart J A |e verfasserin |4 aut | |
700 | 1 | |a van de Vijver, David A M C |e verfasserin |4 aut | |
700 | 1 | |a Boucher, Charles A B |e verfasserin |4 aut | |
700 | 1 | |a Verbon, Annelies |e verfasserin |4 aut | |
700 | 1 | |a Rokx, Casper |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |d 1992 |g 74(2022), 3 vom: 11. Feb., Seite 521-524 |w (DE-627)NLM012603007 |x 1537-6591 |7 nnns |
773 | 1 | 8 | |g volume:74 |g year:2022 |g number:3 |g day:11 |g month:02 |g pages:521-524 |
856 | 4 | 0 | |u http://dx.doi.org/10.1093/cid/ciab445 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 74 |j 2022 |e 3 |b 11 |c 02 |h 521-524 |